Share
Journal Information
Issue
Vol. 13. Issue 1.Pages 4-154 (January - February 2014)
Hepatology highlights
Concise review
The impact of bacterial infections on survival of patients with decompensated cirrhosis
Edna Strauss
Ann Hepatol. 2014;13:7-19
Open access
Original article
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C
Nicola Coppola, Ivan Gentile, Giuseppe Pasquale, Antonio Riccardo Buonomo, Nicolina Capoluongo, Maria D’Armiento, Guglielmo Borgia, Evangelista Sagnelli
Ann Hepatol. 2014;13:20-6
Open access
Diabetes worsening of hepatitis C cirrhosis: Are alterations in monocytic tissue factor (CD 142) is the cause?
Mona A. Abu El Makarem, Mohammed Eslam, Douaa Sayed, Mohamed Shawkat, Naglaa K. Idriss, Elwy M. Soliman, Tahra Sherif, Ragaa Abdelshaheed, ... Sahar Elheney
Ann Hepatol. 2014;13:27-37
Open access
Incidence of hepatocellular carcinoma in hepatitis C cirrhotic patients with and without HIV infection: a cohort study, 1999-2011
Nicolas Di Benedetto, Mirta Peralta, Estela Alvarez, María Teresa Schroder, Claudio Estepo, Silvia Paz, Hugo Fainboim
Ann Hepatol. 2014;13:38-44
Open access
Stem cell and hepatocyte proliferation in hepatitis C cirrhosis and hepatocellular carcinoma: transplant implications
Martha K. Behnke, Mark Reimers, Robert A. Fisher
Ann Hepatol. 2014;13:45-53
Open access
Prediction of poor graft function by means of gastric tonometry in patients undergoing liver transplantation
Valter Perilli, Paola Aceto, Cristina Modesti, Francesca Vitale, Pierpaolo Ciocchetti, Teresa Sacco, Alessia Adduci, Carlo Lai, ... Liliana Sollazzi
Ann Hepatol. 2014;13:54-9
Open access
Predictors of chronic liver disease in individuals with human immunodeficiency virus infection
Nila Rafiq, Maria Stepanova, Brian Lam, Fatema Nader, Manirath Srishord, Zobair M. Younossi
Ann Hepatol. 2014;13:60-4
Open access
Primary prophylaxis with ciprofloxacin in cirrhotic patients with ascites: a randomized, double blind study
Félix Téllez-Ávila, José Sifuentes-Osornio, Varenka Barbero-Becerra, Ada Franco-Guzmán, Roberto Ruiz-Cordero, Roberto Alfaro-Lara, Ángeles Hernández-Ramírez, Florencia Vargas-Vorácková
Ann Hepatol. 2014;13:65-74
Open access
Band ligation vs. N-Butyl-2-cyanoacrylate injection in acute gastric variceal bleeding: a prospective follow-up study
Marcel Tantau, Dana Crisan, Daniel Popa, Stefan Vesa, Alina Tantau
Ann Hepatol. 2014;13:75-83
Open access
Statin use is not associated with liver related mortality
Zahra Younoszai, Li Zheng, Maria Stepanova, Madeline Erario, Rebecca Cable, Zobair M. Younossi
Ann Hepatol. 2014;13:84-90
Open access
Non-invasive methods for the assessment of hepatic fibrosis: transient elastography, hyaluronic acid, 13C-aminopyrine breath test and cytokeratin 18 fragment
Gian Paolo Caviglia, Alessia Ciancio, Chiara Rosso, Maria Lorena Abate, Antonella Olivero, Rinaldo Pellicano, Giovanni Antonio Touscoz, Antonina Smedile, Mario Rizzetto
Ann Hepatol. 2014;13:91-7
Open access
Bilirubin alone as a biomarker for short-term mortality in acute-on-chronic liver failure: an important prognostic indicator
Jorge A. López-Velázquez, Norberto C. Chávez-Tapia, Guadalupe Ponciano-Rodríguez, Vicente Sánchez-Valle, Stephen H. Caldwell, Misael Uribe, Nahum Méndez-Sánchez
Ann Hepatol. 2014;13:98-104
Open access
Effects of bile acid sequestration on hepatic steatosis in obese mice
Nancy Solís, Margarita Pizarro, Pablo Quintero, Juan Pablo Arab, Arnoldo Riquelme, Oslando Padilla, Gonzalo Carrasco, Carlos J. Pirola, ... Marco Arrese
Ann Hepatol. 2014;13:105-12
Open access
Kinetics of the inflammatory response induced by free fatty acid accumulation in hepatocytes
Norberto C. Chávez-Tapia, Natalia Rosso, Misael Uribe, Rafel Bojalil, Claudio Tiribelli
Ann Hepatol. 2014;13:113-20
Open access
Images in hepatology
Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today?
Rolf Teschke, Christian Frenzel
Ann Hepatol. 2014;13:121-6
Open access
Case report
Autoimmune hepatitis in patients with chronic HBV and HCV infections: patterns of clinical characteristics, disease progression and outcome
Eirini I. Rigopoulou, Kalliopi Zachou, Nikolaos Gatselis, George K. Koukoulis, George N. Dalekos
Ann Hepatol. 2014;13:127-35
Open access
Autoimmune liver disorders and small-vessel vasculitis: four case reports and review of the literature
Francesco Tovoli, Antonio Vannini, Marco Fusconi, Magda Frisoni, Daniela Zauli
Ann Hepatol. 2014;13:136-41
Open access
Portal hypertension and acute liver failure as uncommon manifestations of primary amyloidosis
Blanca Norero, Rosa María Pérez-Ayuso, Ignacio Duarte, Pablo Ramirez, Alejandro Soza, Marco Arrese, Carlos Benítez
Ann Hepatol. 2014;13:142-9
Open access
Letter to editor
Serum visfatin in nonalcoholic fatty liver disease
Stergios A. Polyzos, Jannis Kountouras, lordanis Romiopoulos, Vaia Polymerou
Ann Hepatol. 2014;13:150-1
Open access
Liver news elsewhere
Chemokines: potent mediators of hepatic inflammation and fibrosis in chronic liver diseases
Priya Handa, Kris V. Kowdley
Ann Hepatol. 2014;13:152-4
Open access
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
